Interventional Systems
Interventional Systems (INS) is a medical device company developing innovative B2B and OEM robotic solutions for minimally invasive surgery and percutaneous procedures. Its flagship product, Micromate™, is the world’s most versatile miniature robotic platform, cleared for 2D and 3D image-guided, needle-based procedures. Designed for precision, portability, and ease of use, Micromate™ seamlessly integrates with third-party navigation systems and supports multiple surgical specialties. INS partners with other med-tech companies to provide its FDA-cleared, CE-marked platform through flexible licensing and full customization. By managing R&D, regulatory compliance, and manufacturing, INS enables its partners to bring advanced robotic solutions to market quickly and cost-effectively. INS is headquartered in Kitzbühel, Austria, with offices in Austria, Germany, and Portugal.
Interventional Systems
Interventional Systems (INS) is a medical device company developing innovative B2B and OEM robotic solutions for minimally invasive surgery and percutaneous procedures. Its flagship product, Micromate™, is the world’s most versatile miniature robotic platform, cleared for 2D and 3D image-guided, needle-based procedures. Designed for precision, portability, and ease of use, Micromate™ seamlessly integrates with third-party navigation systems and supports multiple surgical specialties. INS partners with other med-tech companies to provide its FDA-cleared, CE-marked platform through flexible licensing and full customization. By managing R&D, regulatory compliance, and manufacturing, INS enables its partners to bring advanced robotic solutions to market quickly and cost-effectively. INS is headquartered in Kitzbühel, Austria, with offices in Austria, Germany, and Portugal.
TL;DR
Headquarters: Kitzbühel, Austria
Flagship product: Micromate — miniature table-mounted robotic platform for image-guided needle interventions
Regulatory status: FDA 510(k) clearance and CE marking
Employees: 33
Notable investor: Ascend Capital Partners (Series A)
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Image-guided minimally invasive and percutaneous needle-based procedures (biopsy, ablation, other needle interventions).
Founded
2010
Industry
Medical Equipment Manufacturing
Funding Track Record
Series A closed on May 4, 2020 (amount obfuscated in available records).
Investor Signal
“Ascend Capital Partners participated in Series A”